Microvascular density and vascular endothelial growth factor have little correlation with prognosis of craniopharyngioma

Surgical Neurology

Volumn 66, Issue SUPPL. 1, 2006, Pages

  Xu, Jianguo ^a,b   Zhang, Sizhong ^a,b   You, Chao ^a   Wang, Xiaojie ^a   Zhou, Qiao ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Craniopharyngioma; Microvessel density; Prognosis; Tumor recurrence; Vascular endothelial growth factor

Indexed keywords

AVIDIN; BIOTIN; PEROXIDASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MICROVASCULARIZATION; PROGNOSIS; QUANTITATIVE ANALYSIS; RECURRENCE RISK; REOPERATION; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE; TUMOR VASCULARIZATION;

CRANIOPHARYNGIOMA; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROCIRCULATION; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33746840099     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2006.05.047     Document Type: Article

References (37)

1. Adamson T.E., Wiestler O.D., Kleihues P., et al. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73 (1990) 12-17
2. Arginteanu M.S., Hague K., Zimmerman R., et al. Craniopharyngioma arising de novo in middle age: case report. J Neurosurg 86 (1997) 1046-1048
3. Bunin G.R., Surawicz T.S., Witman P.A., et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg 89 (1998) 547-551
4. Daniel K.G., Kuhn D.J., Kazi A., et al. Anti-angiogenic and anti-tumor properties of proteasome inhibitors. Curr Cancer Drug Targets 5 (2005) 529-541
5. Demirag F., Unsal E., Yilmaz A., et al. Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma. Chest 128 (2005) 3382-3387
6. DeVile C.J., Grant D.B., Kendall B.E., et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?. J Neurogenet 85 (1996) 73-81
7. Duo D., Gasverde S., Benech F., et al. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis. Clin Neuropathol 22 (2003) 229-234
8. El-Assal O.N., Yamanoi A., Soda Y., et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular, carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in angiogenesis of cirrhotic liver. Hepatology 27 (1998) 1554-1562
9. Elmaci L., Kurtkaya-Yapicier O., Ekinci G., et al. Metastatic papillary craniopharyngioma: case study and study of tumor angiogenesis. Neuro-oncol 4 (2002) 123-128
10. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 69 (2005) 11-16
11. Green A.L., Yeh J.S., and Dias P.S. Craniopharyngioma in a mother and daughter. Acta Neurochir 144 (2002) 404-406
12. Kalapurakal J.A., Goldman S., Hsieh Y.C., et al. Clinical outcome in children with recurrent craniopharyngioma after primary surgery. Cancer J 6 (2000) 388-393
13. Kang J.K., and Lee K.S. Management of craniopharyngioma in children: the present and future. Int Congr Ser 1247 (2002) 165-172
14. Khafaga Y., Jenkin D., Kanaan I., et al. Craniopharyngioma in children. Int J Radiat Oncol Biol Phys 42 (1998) 601-606
15. Kim S.K., Wang K.C., Shin S.H., et al. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Child's Nerv Syst 17 (2001) 531-536
16. Kleihues P., Louis D.N., Scheithauer B.W., et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61 (2002) 215-225
17. Li S.Q. Craniopharyngioma. In: Xu Q.W., and Jiang Y.P. (Eds). Clinical cranio-brain disease (2003), Science and Technology Publisher, Tianjin 278-283 [Chinese]
18. Losa M., Vimercati A., Acerno S., et al. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry 75 (2004) 889-892
19. Lubansu A., Ruchoux M.M., Brotchi J., et al. Cathepsin B, D and K expression in adamantinomatous craniopharyngiomas relates to their levels of differentiation as determined by the patterns of retinoic acid receptor expression. Histopathology 43 (2003) 563-572
20. Dusik-Sharpe J. Kerry's story: the challenges of facing a recurrent craniopharyngioma. Axone 26 (2004) 8-12
21. Matsuo M., Yonemitsu N., Zaitsu M., et al. Expression of prostaglandin H synthase-2 in human brain tumors. Acta Neuropathol, Suppl 102 (2001) 181-187
22. Muller H.L., Kaatsch P., and Warmuth M.M. Childhood craniopharyngioma: current concepts in diagnostics and therapy. Monatsschr Kinderh 151 (2003) 1056-1063
23. Nishi T., Kuratsu J., Takeshima H., et al. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma. Int J Mol Med 3 (1999) 157-161
24. Pan J., Qi S.T., and Deng Y.J. Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence. J First Mil Med Univ 22 (2002) 363-365
25. Pan L.X., Liu Y.S., and Cheng Z.P. Correlation expression of MVD and VEGF with invasion of hypophysoma. Chin J Neurosurg 19 (2003) 285-287
26. Poretti A., Grotzer M.A., Ribi K., et al. Outcome of a craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46 (2004) 220-229
27. Raghavan R., Dickey W.T., Margraf L.R., et al. Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children. Surg Neurol 54 (2000) 241-248
28. Rienstein S., Adams E.F., Pilzer D., et al. Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg 98 (2003) 162-164
29. Samoto K., Ikezaki K., Ono M., et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55 (1995) 1189-1193
30. Sarubi J.C., Bei H., Adams E.F., et al. Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsà and Gi2à gene. Neurosci Lett 310 (2001) 5-8
31. Sauter E.R., Nesbit M., Watson J.C., et al. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 5 (1999) 775-782
32. Shin J.L., Asa S.L., Woodhouse L.J., et al. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab 84 (1999) 3972-3982
33. Stiver S.I., Tan X., Brown L.F., et al. VEGF-A angiogenesis induces a stable neovasculature in adult murine brain. J Neuropathol Exp Neurol 63 (2004) 841-855
34. Ulfarsson E., Karström A., Yin S., et al. Expression and growth dependency of the insulin-like growth factor 1 receptor in craniopharyngioma cells: a novel therapeutic approach. Clin Cancer Res 11 (2005) 4674-4680
35. Wang K.C., Kim S.K., Chone G.Y., et al. Growth patterns of craniopharyngioma in children: role of the diaphragm sellae and its surgical implication. Surg Neurol 57 (2002) 25-33
36. Weiner H.L., Wisoff J.H., Rosenberg M.E., et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35 (1994) 1001-1011
37. Younes A. Angiogenesis in lymphoma: a short review. Curr Mol Med 5 (2005) 609-613